摘要
血栓性疾病是目前危害人类健康的第一大健康杀手,微生物发酵制备纤溶因子安全性高,是国内外筛选特异性强的溶栓剂常用方法之一。综述了纤溶菌(或纤溶酶)来源、纤溶酶制备和溶栓发酵液的其他生物活性,并对微生物发酵制备纤溶因子的未来发展方向进行了展望。
Thrombos, one of the most harmful diseases, is harmful to human health. The method of fermentation used to prepare fibrinolytic a- gents is considered as one of the most common approaches to select effective fibrinolytic agents. The sources of fibrinolytic bacterial strains or fibrinolytic enzyme, preparation of fibrinolytic enzyme and other bioactivities of fibrinolytic fermentation were summarized. In addition, the po- tential research aims of fibrinolytic fermentation were proposed.
出处
《安徽农业科学》
CAS
2013年第31期12452-12454,共3页
Journal of Anhui Agricultural Sciences
基金
浙江省水产品加工产业创新团队项目(2011R09031-08)
浙江海洋学院科研启动经费资助项目
浙江海洋学院大学生科技创新项目(2012年)
关键词
血栓
纤溶性
微生物
发酵
Thrombosis
Fibrinolytic activity
Microbe
Fermentation